Levels Of You

Most people think laser hair growth technology was designed specifically for hair loss.

It wasn’t.

Back in the 1960s, researcher Endre Mester was investigating whether low-powered lasers could help treat cancer in mice. But instead of curing the implanted tumours, he noticed something completely unexpected…

The mice exposed to the laser grew hair faster than the control group.

That accidental observation would go on to become the foundation of Low-Level Laser Therapy (LLLT) and decades of research into light-based hair restoration.

Sometimes the biggest breakthroughs in medicine aren’t discovered by finding what you’re looking for.

They’re discovered by noticing what nobody expected.

Dr Jonathan Hopkirk, AHPRA Registration No: MED0001681727

Medical Disclaimer: This content is provided for educational purposes only and does not constitute medical advice. All medical treatments carry potential risks, benefits, side effects, and limitations. Not all treatments are suitable for every individual. Results vary between patients and depend on factors including diagnosis, genetics, medical history, and treatment adherence. Always seek personalised advice from a qualified healthcare professional before commencing treatment.

Everyone is talking about the new hair loss ingredient VDPHL01… but why?

It’s not necessarily because it’s more powerful than oral minoxidil.

It’s because the drug was designed differently.

Traditional oral minoxidil creates a spike in drug levels after you take it, followed by a gradual decline throughout the day.

VDPHL01 uses an extended-release formulation that aims to deliver minoxidil more steadily over time.

The theory?

📌 More consistent drug exposure

📌 Potentially similar or better hair growth

📌 Potentially fewer side effects by avoiding high peak concentrations

This is why some people are already calling it “Minoxidil 2.0.”

The important caveat: we still need longer-term data and peer-reviewed publications before we know whether these theoretical advantages translate into real-world benefits.
Dr Jonathan Hopkirk
AHPRA Registration: MED0001945611

Medical Disclaimer: All medical treatments carry potential risks, side effects, benefits, and limitations. These risks are unique to both the treatment being considered and the individual receiving it, and are discussed in detail during consultation with one of our doctors before any treatment is commenced. Not all treatments are suitable for every patient. Results vary between individuals and depend on multiple factors including the cause of hair loss, medical history, and adherence to treatment. Any pricing or treatment information is general in nature and subject to consultation.

Most people assume laser hair removal can only do one thing:

Remove hair.

But under certain circumstances, the opposite can happen.

It’s called Paradoxical Hypertrichosis a rare but recognised phenomenon where laser treatment stimulates additional hair growth instead of reducing it.

In this short, I explain how this happened to me personally and why treatment settings matter.

One of the leading theories is that when energy levels are too low to permanently damage the hair follicle, the light may instead provide a stimulatory effect to the follicle and surrounding tissue.

Ironically, this is one of the reasons low-level light therapies are being investigated and used for hair growth in completely different settings.

The same technology can produce very different outcomes depending on wavelength, energy delivery, treatment parameters, and the biological target.

Medicine is rarely as simple as “laser equals hair removal.”

Sometimes the biology has other plans.

Dr Jonathan Hopkirk
AHPRA Registration No: MED0001945611

Medical Disclaimer: This content is provided for educational purposes only and does not constitute medical advice. All medical treatments carry potential risks, benefits, side effects, and limitations. Not all treatments are suitable for every individual. Results vary between patients and depend on factors including diagnosis, genetics, medical history, and treatment adherence. Always seek personalised advice from a qualified healthcare professional before commencing any medical treatment.

PP405 results just LEAKED from a conference in Denver 👀

Real before and after images are now circulating and they’re showing something we haven’t seen before in hair loss treatment…

👉 Hair regrowth from follicles that were previously thought to be inactive

This is not your typical approach to hair loss.
PP405 is targeting follicular stem cells, aiming to reactivate growth rather than just slow down loss.

But here’s where it gets interesting…
Are we looking at a genuine breakthrough or early stage data being overhyped?

In this video, I break down what’s real, what’s still unknown, and what this could actually mean for the future of hair restoration.

menshealth dermatology biotech beforeandafter hairtreatment

⸻

Medical Disclaimer: This video is for educational purposes only and does not constitute medical advice, diagnosis, or personalised treatment. Always consult a qualified healthcare professional before starting, stopping, or changing any medication. Individual results may vary.

Not all hair loss shampoos are created equal.

🧴 Nizoral® 2% (Ketoconazole) – The strongest evidence of the three. Studies suggest ketoconazole may improve hair density and hair shaft diameter while helping reduce scalp inflammation.

☕ Alpecin® (Caffeine) – Laboratory and clinical studies suggest caffeine may help support hair growth and reduce shedding by counteracting some of the effects of DHT on the follicle.

🌿 Nioxin Hair Fall Defence (Sandalore™️) – Sandalore activates receptors within the hair follicle that may help prolong the hair growth phase, although more clinical research is needed.

A shampoo alone is rarely enough to reverse established pattern hair loss, but choosing one with evidence-backed ingredients can be a useful part of a broader hair restoration plan such as our HRP™️ (Hair Restoration Protocol).

Key references:
• Piérard-Franchimont et al. Dermatology. 1998 (Ketoconazole)
• Fischer et al. Skin Pharmacology & Physiology. 2014 (Caffeine)
• Chéret et al. Nature Communications. 2018 (Sandalore™️)

Dr Jonathan Hopkirk | AHPRA Registration No: MED0001945611

Medical Disclaimer: This content is provided for educational purposes only and does not constitute medical advice. Results vary between individuals. Always seek personalised advice from a qualified healthcare professional.